Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
NCT02236312
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
359
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
DRUG:
Botulinum Toxin Type A
DRUG:
Placebo
Sponsor
Galderma R&D